Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 3.55 CAD -2.2% Market Closed
Market Cap: 97.3m CAD
Have any thoughts about
Covalon Technologies Ltd?
Write Note

Covalon Technologies Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Covalon Technologies Ltd
Cost of Revenue Peer Comparison

Comparables:
B
DRUG
TH
RPTX
AUPH
EDT

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Covalon Technologies Ltd
XTSX:COV
Cost of Revenue
-CA$12.7m
CAGR 3-Years
9%
CAGR 5-Years
-1%
CAGR 10-Years
-18%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Cost of Revenue
-$19.4m
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
-21%
Repare Therapeutics Inc
NASDAQ:RPTX
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cost of Revenue
-$28.8m
CAGR 3-Years
-331%
CAGR 5-Years
N/A
CAGR 10-Years
-107%
Spectral Medical Inc
TSX:EDT
Cost of Revenue
-CA$1.2m
CAGR 3-Years
-22%
CAGR 5-Years
-17%
CAGR 10-Years
-3%

See Also

What is Covalon Technologies Ltd's Cost of Revenue?
Cost of Revenue
-12.7m CAD

Based on the financial report for Jun 30, 2024, Covalon Technologies Ltd's Cost of Revenue amounts to -12.7m CAD.

What is Covalon Technologies Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-18%

Over the last year, the Cost of Revenue growth was -3%. The average annual Cost of Revenue growth rates for Covalon Technologies Ltd have been 9% over the past three years , -1% over the past five years , and -18% over the past ten years .

Back to Top